(Press-News.org) According to a new paper in Rheumatology, published by Oxford University Press, JAK inhibitors, which doctors have used to treat patients with arthritis despite concerns about the effectiveness of such drugs, actually do work quite well. In a multicenter, retrospective study Japanese researchers found that the drugs resulted in impressive remission rates in patients, most of whom choose to continue such treatment.
Rheumatoid arthritis is a common autoimmune disease characterized by chronic inflammation of joint linings and results in progressive joint destruction and other systemic complications. The use of biological disease-modifying drugs enables patients to enjoy the achievement of low disease activity and remission. But clinics must administer such drugs through subcutaneous or intravenous routes, which is unpleasant for patients, and over time these drugs commonly become less effective.
Recently scientists have developed Janus kinase (JAK) inhibitors for arthritis treatment. Patients take such drugs orally. Previous research has demonstrated the efficacy and safety of JAK inhibitors in randomized controlled trials. However, some researchers have questioned the potential efficacy of JAK inhibitors for widespread patient use. In practice, doctors mostly treat patients with JAK inhibitors precisely because those patients have other health problems and so conventional drugs like methotrexate are less effective on them. Real-world patients have distinctive characteristics compared with the patients recruited in randomized controlled trials.
In the present multicenter, retrospective study, researchers using data from 622 patients treated at seven major university hospitals in Japan compared the efficacy and safety of four common JAK inhibitors: tofacitinib, baricitinib, peficitinib, and upadacitinib.
The researchers here found that approximately one in three patients reached remission, three in four reached at least low disease activity, with both numbers representing impressive efficacy. They noted that more than 80% of the patients were still on the JAK inhibitor drugs after six months.
They believe that this is particularly relevant given that immunological secondary treatment failure, where drugs cease to be effective because they produce adverse immune system responses in patients, cannot occur with these oral medications. Immunological secondary treatment failure is common in patients who treat their arthritis with drugs like methotrexate.
The paper, “Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study,” is available (at midnight on November 1st) at: https://doi.org/10.1093/rheumatology/kead543.
Direct correspondence to:
Shinya Hayashi
Department of Orthopedic Surgery
Kobe University Graduate School of Medicine
7-5-1 Kusunoki-cho, Chuo-ku
Kobe 650-0017, JAPAN
shayashi@med.kobe-u.ac.jp
To request a copy of the study, please contact:
Daniel Luzer
daniel.luzer@oup.com
END
Study finds JAK inhibitors, common treatment for arthritis, are effective
2023-11-01
ELSE PRESS RELEASES FROM THIS DATE:
Do mild depressive and anxiety symptoms in fathers predict behavioral and cognitive problems in their children?
2023-11-01
While the role of mothers’ stress, anxiety and depression on children’s behavioral and cognitive development is well established, less is known about the connection between fathers’ mental health and children’s development.
Now, a team of researchers affiliated to different institutions across Quebec, Canada has examined if paternal anxious and depressive symptoms, measured during their partner’s pregnancy, and again six to eight years later, are associated with children’s cognitive function and behavior. They studied this association ...
Cancer drug could hold hope for treating inflammatory diseases including gout and heart diseases
2023-11-01
A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say scientists at the University of Cambridge.
In a study published today in the Journal of Clinical Investigation, the researchers have identified a molecule that plays a key role in triggering inflammation in response to materials in the body seen as potentially harmful.
We are born with a defence system known as innate immunity, which acts as the first line of defence against harmful materials in the body. Some of these materials will come from outside, such as bacterial or viral ...
New cancer drug shows promise targeting genetic weakness in tumors, comments Virginia Tech expert
2023-11-01
Imagine the body’s cells are well-behaved students in the classroom. The “teachers” are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.
With cells, this is a serious matter. Unregulated behavior can lead to uncontrolled growth and, ultimately, the development of cancer.
In an invited review article Wednesday (Nov. 1, 2023) in Cancer Discovery, a journal of the American Association for Cancer Research, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the ...
Marine oxygen landscape shaped by plate movement and biological innovation
2023-11-01
The oxygen content of seawater has a profound impact on the cycling of bioessential elements and the habitability of Earth. But how and why the marine oxygen landscape (i.e., the spatial pattern of oxygen levels) evolved since the start of the Phanerozoic 538 million years ago is not well established.
To tackle this problem, researchers led by Prof. WANG Xiangli from the Institute of Geology and Geophysics of the Chinese Academy of Sciences (IGGCAS) and Prof. LI Chao from the Chengdu University of Technology, along with collaborators from the University of Cincinnati and the Nanjing Institute of Geology and Palaeontology, have reconstructed a nearly continuous record of ...
Having a bad boss makes you a worse employee
2023-11-01
uIf your boss stomps and yells, criticizes you, and then proceeds to take the credit for your work – even it is an isolated incident – it can take a profound toll on employee well-being and performance. But despite the many years of research, the precise mechanisms through which bad leadership impacts employees’ performance remain a subject of interest.
In a new study, first published online Oct. 30 in Group & Organization Management, an international group of researchers, led by Stevens Institute of Technology and University of Illinois Chicago, offer a novel explanation of the cognitive factors through which abusive ...
Non-invasive technology maps brain activity to investigate behavior changes in neurological disease
2023-11-01
A research team led by Cleveland Clinic and Oregon Health and Science University (OHSU) has developed a new method for mapping how the parts of the brain "speak" to each other, critical to understanding behavior changes in patients with neurological disease.
Diseases like Alzheimer's disease change how patients communicate and act, affecting their relationships and well-being. Cleveland Clinic's Hod Dana, PhD, is collaborating with Jacob Raber, PhD, an OHSU behavioral neuroscientist, on ...
NIH funding helps Ghose Lab invest in innovative imaging equipment
2023-11-01
UTA will soon add a new piece of cutting-edge equipment to its already impressive and growing research armamentarium—a type of super-resolution microscope (SRM) that allows biologists to see structures within a cell in even finer detail.
The SRM will come to UTA because of additional grant funding from the National Institutes of Health (NIH) to the lab of Piya Ghose, an assistant professor of biology at UTA. This nearly $250,000 award supplements Ghose’s existing NIH/National Institute of General Medical ...
Domestic violence involving firearms increased during COVID-19 pandemic
2023-11-01
(SACRAMENTO, Calif.) — Domestic violence went down or stayed the same during the first 10 months of the COVID-19 pandemic in five major U.S. cities. However, domestic violence involving firearms increased in three of those cities, according to a new UC Davis study published in the Journal of Family Violence.
“The increase in firearm domestic violence is concerning, as abuser firearm access is a risk factor for lethality,” said Elizabeth Tomsich, a research data analyst at the UC Davis Violence Prevention Research Center and ...
Microbiology: River plastics may harbour potential pathogens and antimicrobial resistance genes
2023-11-01
Microbial communities growing on plastic debris in rivers may have the capacity to harbour potentially pathogenic microbes and act as reservoirs of antimicrobial resistance genes, according to a study published in Microbiome. The findings also highlight differences in the potential pathogens and antimicrobial resistance genes that new and degraded plastics may have the capacity to harbour.
Vinko Zadjelovic, Elizabeth Wellington, Joseph Christie-Oleza and colleagues characterised the microbial communities found on the surface ...
High metabolism is an early sign of Alzheimer’s disease
2023-11-01
An early phase in the process of developing Alzheimer’s disease is a metabolic increase in a part of the brain called the hippocampus, report researchers from Karolinska Institutet in a study published in Molecular Psychiatry. The discovery opens up for new potential methods of early intervention.
Alzheimer’s disease is the most common form of dementia and strikes about 20,000 people in Sweden every year. Researchers now show that a metabolic increase in the mitochondria, the cellular power ...